HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 83 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2022. The put-call ratio across all filers is 29.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,998 | +39.7% | 2,715 | -1.1% | 0.00% | – |
Q2 2023 | $32,938 | -63.4% | 2,745 | -60.3% | 0.00% | – |
Q1 2023 | $89,948 | -7.6% | 6,908 | +4.8% | 0.00% | – |
Q4 2022 | $97,386 | -39.5% | 6,589 | -63.7% | 0.00% | – |
Q3 2022 | $161,000 | +35.3% | 18,133 | +92.3% | 0.00% | – |
Q2 2022 | $119,000 | -69.3% | 9,429 | -54.1% | 0.00% | – |
Q1 2022 | $388,000 | -51.8% | 20,540 | -10.5% | 0.00% | – |
Q4 2021 | $805,000 | +317.1% | 22,943 | +335.8% | 0.00% | – |
Q3 2021 | $193,000 | – | 5,265 | +131525.0% | 0.00% | – |
Q2 2021 | $0 | – | 4 | -42.9% | 0.00% | – |
Q4 2020 | $0 | – | 7 | -12.5% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 8 | -100.0% | 0.00% | -100.0% |
Q2 2020 | $7,060,000 | -43.4% | 255,980 | -63.3% | 0.00% | -50.0% |
Q1 2020 | $12,466,000 | -68.9% | 698,378 | -56.3% | 0.00% | -50.0% |
Q4 2019 | $40,045,000 | +48.6% | 1,597,346 | +5.7% | 0.00% | +33.3% |
Q3 2019 | $26,956,000 | +63.4% | 1,510,948 | +101.5% | 0.00% | +50.0% |
Q2 2019 | $16,500,000 | – | 750,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERAL ATLANTIC, L.P. | 4,000,000 | $67,760,000 | 1.05% |
M&G INVESTMENT MANAGEMENT LTD | 7,084,834 | $120,442,178 | 0.54% |
Bellevue Group AG | 1,802,963 | $30,584,761 | 0.49% |
AIA Group Ltd | 391,278 | $6,628,249 | 0.32% |
PLATINUM INVESTMENT MANAGEMENT LTD | 182,052 | $3,083,961 | 0.12% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 4,219,168 | $71,472,706 | 0.11% |
Hennion & Walsh Asset Management, Inc. | 51,735 | $876,391 | 0.06% |
Allianz Asset Management GmbH | 1,644,999 | $27,866,283 | 0.05% |
Janney Capital Management LLC | 17,203 | $291 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 193,811 | $3,268 | 0.01% |